{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T01:24:44Z","timestamp":1789435484619,"version":"build-2803163510"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T00:00:00Z","timestamp":1659484800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012401","name":"Beijing Science and Technology Planning Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012401","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016966","name":"Bethune Charitable Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016966","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Aims<\/jats:title><jats:p>To describe the long-term effect of scleral buckling (SB) surgery for stage 4A retinopathy of prematurity (ROP).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A retrospective chart review was conducted for patients with a diagnosis of stage 4A ROP who underwent SB between October 2010 and October 2021. Basic data were collected from patient charts, including gender, birth weight, gestational age at birth, disease stage, presence of plus disease, preoperative treatment [laser photocoagulation, intravitreal anti-vascular endothelial growth factor (VEGF) agent therapy, or a combination of both] and complications (vitreous hemorrhages), postmenstrual age at surgery, intraoperative combined treatment, and total length of follow-up. Retinal attachment status after surgery, postoperative complications (glaucoma, cataract), date and type of subsequent retinal surgeries (if performed), and refractive status 1 year after surgery were evaluated. The follow-up time after the first procedure was over 1 year.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Six-two eyes from forty-eight patients met the inclusion criteria for this study. The initial reattachment rate was 93.5% (58\/62 eyes), and the final reattachment rate was 100% after two procedures at the end of follow-up. The incidence of cataracts was 3.2% (2\/62), with no eye subsequently needing lensectomy surgery. None of the patients developed glaucoma during the follow-up time. The average spherical equivalent refraction value for patients was \u22123.00 \u00b1 2.51 D (\u22127.60 D to +2.75 D) 1 year after surgery.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>SB, especially segmental buckling, which induces less myopia and does not require buckle removal, has the potential to provide a significant positive impact in the treatment of stage 4A ROP.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2022.969861","type":"journal-article","created":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T04:40:01Z","timestamp":1659501601000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Evaluation of segmental scleral buckling surgery for stage 4A retinopathy of prematurity in China"],"prefix":"10.3389","volume":"9","author":[{"given":"Yusheng","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yating","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingwei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/S0140-6736(13)60178-6","article-title":"Retinopathy of prematurity.","volume":"382","author":"Hellstr\u00f6m","year":"2013","journal-title":"Lancet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e1004","DOI":"10.1111\/aos.14460","article-title":"Comparison of the effectiveness of conbercept and ranibizumab treatment for retinopathy of prematurity.","volume":"98","author":"Cheng","year":"2020","journal-title":"Acta Ophthalmol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/j.ophtha.2020.12.028","article-title":"Retinal detachment after treatment of retinopathy of prematurity with laser versus intravitreal anti-vascular endothelial growth factor.","volume":"128","author":"Barry","year":"2021","journal-title":"Ophthalmology."},{"key":"B4","doi-asserted-by":"publisher","first-page":"79","DOI":"10.18240\/ijo.2019.01.12","article-title":"Fluorescein angiography of retinal vascular involution after intravitreal injection of ranibizumab for retinopathy of prematurity.","volume":"12","author":"Cheng","year":"2019","journal-title":"Int J Ophthalmol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1097\/IAE.0b013e318159ec49","article-title":"25-Gauge lens-sparing vitrectomy for stage 4A retinopathy of prematurity.","volume":"28","author":"Kychenthal","year":"2008","journal-title":"Retina."},{"key":"B6","first-page":"185","article-title":"Surgical management in advanced stages of retinopathy of prematurity.","volume":"4","author":"Roohipoor","year":"2009","journal-title":"J Ophthalmic Vis Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1097\/ICU.0b013e328309f1a5","article-title":"Surgical management of retinopathy of prematurity.","volume":"19","author":"Hubbard","year":"2008","journal-title":"Curr Opin Ophthalmol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1080\/17469899.2019.1596026","article-title":"A review of treatment for retinopathy of prematurity.","volume":"14","author":"Hansen","year":"2019","journal-title":"Expert Rev Ophthalmol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1136\/bjophthalmol-2011-301353","article-title":"Long-term visual outcomes following lens-sparing vitrectomy for retinopathy of prematurity.","volume":"96","author":"Singh","year":"2012","journal-title":"Br J Ophthalmol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1097\/00006982-200410000-00011","article-title":"Comparison of retinal outcomes after scleral buckle or lens-sparing vitrectomy for stage 4 retinopathy of prematurity.","volume":"24","author":"Hartnett","year":"2004","journal-title":"Retina."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1038\/eye.2015.78","article-title":"Safety and efficacy of simultaneous bilateral 25-gauge lens-sparing vitrectomy for vascularly active stage 4 retinopathy of prematurity.","volume":"29","author":"Shah","year":"2015","journal-title":"Eye."},{"key":"B12","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.ajo.2007.01.017","article-title":"Anatomic success of lens-sparing vitrectomy with and without scleral buckle for stage 4 retinopathy of prematurity.","volume":"143","author":"Sears","year":"2007","journal-title":"Am J Ophthalmol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.ajo.2009.05.027","article-title":"Evaluation of scleral buckling for stage 4A retinopathy of prematurity by fluorescein angiography.","volume":"148","author":"Yokoi","year":"2009","journal-title":"Am J Ophthalmol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1001\/archopht.123.7.991","article-title":"The international classification of retinopathy of prematurity revisited.","volume":"123","year":"2005","journal-title":"Arch Ophthalmol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"374","DOI":"10.3928\/1542-8877-20000901-04","article-title":"Scleral buckling for stage 4 retinopathy of prematurity.","volume":"31","author":"Chuang","year":"2000","journal-title":"Ophthalmic Surg Lasers."},{"key":"B16","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S0008-4182(03)80090-X","article-title":"Outcomes of primary scleral buckling for stage 4 Retinopathy of prematurity.","volume":"38","author":"Beyrau","year":"2003","journal-title":"Can J Ophthalmol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/s0161-6420(94)31362-5","article-title":"Scleral buckling for retinopathy of prematurity.","volume":"101","author":"Trese","year":"1994","journal-title":"Ophthalmology."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1016\/S0161-6420(98)91023-5","article-title":"Scleral buckling surgery for active stage 4A retinopathy of prematurity.","volume":"105","author":"Hinz","year":"1998","journal-title":"Ophthalmology."},{"key":"B19","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1007\/s10384-015-0401-5","article-title":"Buckling surgery and supplemental intravitreal bevacizumab or photocoagulation on stage 4 retinopathy of prematurity eyes.","volume":"59","author":"Futamura","year":"2015","journal-title":"Jpn J Ophthalmol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1001\/archopht.121.12.1684","article-title":"Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial.","volume":"121","year":"2003","journal-title":"Arch Ophthalmol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1471-2415-8-23","article-title":"Outcome of retinopathy of prematurity patients following adoption of revised indications for treatment.","volume":"8","author":"Alme","year":"2008","journal-title":"Bmc Ophthalmol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1136\/bjo.2006.098582","article-title":"The early treatment for retinopathy of prematurity study: structural findings at age 2 years.","volume":"90","author":"Good","year":"2006","journal-title":"Br J Ophthalmol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1001\/archophthalmol.2011.253","article-title":"Modified 23-gauge vitrectomy system for stage 4 retinopathy of prematurity.","volume":"129","author":"Wu","year":"2011","journal-title":"Arch Ophthalmol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1016\/j.ophtha.2004.06.021","article-title":"Visual outcomes after lens-sparing vitrectomy for stage 4A retinopathy of prematurity.","volume":"111","author":"Prenner","year":"2004","journal-title":"Ophthalmology."},{"key":"B25","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1136\/bjophthalmol-2016-309198","article-title":"Long-term functional results following vitrectomy for advanced retinopathy of prematurity.","volume":"101","author":"Karacorlu","year":"2017","journal-title":"Br J Ophthalmol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"267","DOI":"10.4103\/0301-4738.53050","article-title":"Functional and anatomical outcomes after primary lens-sparing pars plana vitrectomy for Stage 4 retinopathy of prematurity.","volume":"57","author":"Bhende","year":"2009","journal-title":"Indian J Ophthalmol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/j.ophtha.2005.03.031","article-title":"Anatomic success rate after 3-port lens-sparing vitrectomy in stage 4A or 4B retinopathy of prematurity.","volume":"112","author":"Lakhanpal","year":"2005","journal-title":"Ophthalmology."},{"key":"B28","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.ophtha.2014.11.004","article-title":"Long-term outcomes on lens clarity after lens-sparing vitrectomy for retinopathy of prematurity.","volume":"122","author":"Nudleman","year":"2015","journal-title":"Ophthalmology."},{"key":"B29","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1001\/archopht.124.1.20","article-title":"Lens clarity after 3-port lens-sparing vitrectomy in stage 4A and 4B retinal detachments secondary to retinopathy of prematurity.","volume":"124","author":"Lakhanpal","year":"2006","journal-title":"Arch ophthalmol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"917","DOI":"10.4103\/ijo.IJO_33_18","article-title":"Short-term incidence and management of glaucoma after successful surgery for stage 4 retinopathy of prematurity.","volume":"67","author":"Chandra","year":"2019","journal-title":"Indian J Ophthalmol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.ophtha.2017.11.009","article-title":"Glaucoma after lens-sparing vitrectomy for advanced retinopathy of prematurity.","volume":"125","author":"Nudleman","year":"2018","journal-title":"Ophthalmology."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1136\/bjophthalmol-2018-312922","article-title":"Parameters affecting postoperative success of surgery for stage 4A\/4B ROP.","volume":"103","author":"\u00d6zsaygili","year":"2019","journal-title":"Br J Ophthalmol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1007\/bf02343046","article-title":"Scleral buckling surgery in stage 4 retinopathy of prematurity.","volume":"234","author":"Ricci","year":"1996","journal-title":"Graefes Arch Clin Exp Ophthalmol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1001\/archopht.116.11.1446","article-title":"Refractive changes associated with scleral buckling and division in retinopathy of prematurity.","volume":"116","author":"Chow","year":"1998","journal-title":"Arch Ophthalmol."},{"key":"B35","first-page":"300","article-title":"Refractive outcomes of three-port lens-sparing vitrectomy for retinopathy of prematurity.","volume":"107","author":"Holz","year":"2009","journal-title":"Trans Am Ophthalmol Soc."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.969861\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T04:40:06Z","timestamp":1659501606000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.969861\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,3]]},"references-count":35,"alternative-id":["10.3389\/fmed.2022.969861"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.969861","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,3]]},"article-number":"969861"}}